Category: Workers Comp

505 posts found

Medmonitor

Tornado Damages Pfizer Pharmaceutical Plant, Drug Shortages May Follow

As other Pfizer plants shift gears to make up for this damage, overall drug manufacturing may slow in some areas.

This Month's Must Read

3 Ways the Digital Experience Can Drive Meaningful Engagement for Injured Workers

Helpful tips for addressing injured worker unfamiliarity with workers’ comp.

Clinical Insights

Utilization of Opioid Use Disorder Medications

According to JAMA, only 22% of OUD patients received medication-assisted therapy.

Legislation & Policy

Missouri Enacts PTSD Presumption for First Responders

The national trend continues, in this case with qualifying events and the inclusion of 911 dispatchers.

Opioid Developments

FDA Approves Second OTC Naloxone Nasal Spray for Opioid Overdose

RiVive will soon be available without a prescription for the treatment of known or suspected opioid overdose.

Healthe Developments

Connect with Healthe at National Comp 2023!

Stop by our educational session or visit our booth for the latest issue of RxInformer magazine.

Medmonitor

FDA Publishes Guidance on Clinical Trials for Psychedelic Drugs

These guidelines advise researchers on study design and other considerations as they develop medications that contain psychedelics.

This Month's Must Read

A Moment of Clarity: Alcohol’s Impact Across Workers and Medical Management

How problematic alcohol use can impact the workplace, claims, and medication management.

Clinical Insights

Medical Cannabis Makes Little Impact on Pain Management in Group Health

A new study uses data from 583,000 group health patients with chronic noncancer pain.

Legislation & Policy

Connecticut Passes PTSD Presumption for All Employees

Employees who experience a qualifying traumatic event on the job can receive PTSD coverage via workers’ comp.

Healthe Developments

Spotlight on Healthesystems Pharmacists

Jeanette Connelly was named President of the Florida Pharmacy Association, and Silvia Sacalis was featured in a video spotlight by Business Insurance.

Medmonitor

Brixadi Approved for Opioid Use Disorder

A new buprenorphine injection will be available for weekly or monthly dosages, administered by providers.

This Month's Must Read

More Than Skin Deep: Untangling Topical Drug Classes and Costs

An infographic breakdown of the diverse drug categories that comprise dermatological prescribing and spend.

Industry Trends

Low-Volume, High Cost Medications in California

A new report from the CWCI highlights trends in dermatologicals, opioids, and antidepressants.

Opioid Developments

FDA Approves New Drug for Opioid Overdose Reversal

Opvee is a nalmefene hydrochloride nasal spray – a new option available for the reversal of opioid overdose.

Prev 1 2 3 4 5 … 7 8 9 10 11 … 30 31 32 33 34 Next